Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report
ConclusionsUnder a combination of leflunomide and methotrexate, liver toxicity and, for the first time, thrombotic microangiopathy occurred as side effects. Non-alcoholic fatty liver disease may have predisposed for the drug-induced liver toxicity.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Alcoholism | Anemia | Arthritis | Cirrhosis | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | General Medicine | Influenza | Insulin | Laboratory Medicine | Liver | Liver Disease | Metabolic Syndrome | Methotrexate | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Rheumatoid Arthritis | Rheumatology | Steroid Therapy | Thrombocytopenia | Toxicology | Urinary Tract Infections | Urology & Nephrology | Vitamin K | Vitamins